Akebia Therapeutics (AKBA) Restructuring Costs (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Restructuring Costs of $58000.0 for Q1 2024, down 45.28% year-over-year from $106000.0 in Q2 2023, and down 65.68% quarter-over-quarter from $169000.0 in Q3 2023.
Akebia Therapeutics (AKBA) Restructuring Costs (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Restructuring Costs for 5 consecutive years, with $58000.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Restructuring Costs fell 45.28% year-over-year to $58000.0; the TTM figure through Dec 2024 stood at $58000.0 (down 67.96% YoY), while the FY2024 annual figure was $58000.0, down 67.96% from the prior year.
- Restructuring Costs eased to $58000.0 in Q1 2024 per AKBA's latest filing, from $169000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $14.5 million in Q2 2022 and bottomed at -$94000.0 in Q2 2023.
- Historically, Restructuring Costs has averaged $2.3 million across 3 years, with a median of $169000.0 in 2023.
- On a YoY basis, Restructuring Costs climbed as much as 6.11% in 2023 and fell as far as 100.65% in 2023.
- Akebia Therapeutics' Restructuring Costs stood at $1.2 million in 2022, then plunged by 86.17% to $169000.0 in 2023, then sank by 65.68% to $58000.0 in 2024.
- Business Quant data shows AKBA's Restructuring Costs at $58000.0 in Q1 2024, $169000.0 in Q3 2023, and -$94000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Akebia Therapeutics | 240.57 Mn | 85.02 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.95 Mn |
| Mar 31, 2024 | 58,000.00 |
| Sep 30, 2023 | 169,000.00 |
| Jun 30, 2023 | -94,000.00 |
| Mar 31, 2023 | 106,000.00 |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 180,000.00 |
| Jun 30, 2022 | 14.53 Mn |
| Sep 30, 2014 | 10,914.00 |
| Sep 30, 2013 | 2,601.00 |